Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9607 posts found.

amanda_callaghan

ABPI appoints communications director

November 11, 2010 Research and Development, Sales and Marketing ABPI, Amanda Callaghan, Royal College of Nursing, appointment, research and development, sales and marketing

UK industry body the ABPI has appointed Amanda Callaghan director of corporate communications. She starts the role on 31 January …
Appointment

Pfizer enters drug repositioning collaboration with Biovista

November 11, 2010 Research and Development Biovista, FDA, Neurontin, Pfizer, Pfizer Indications Discovery Unit, drug repositioning, viagra

Pfizer has signed a pilot research agreement with drug repositioning specialist Biovista. The aim of the collaboration is to identify …
News

Patients in UK cancer trials quadruples

November 11, 2010 Research and Development Cancer Research UK, NCRI, National Cancer Research Institute, UK clinical research, cancer trials

The number of cancer patients in the UK participating in clinical studies has quadrupled in the last decade, according to …
News

Novartis drops late stage lung cancer candidate

November 11, 2010 Research and Development ASA404, Antisoma, NSCLC, Novartis, cancer research, lung cancer, non small cell lung cancer, non-small cell lung cancer

Novartis has discontinued phase III trials for its lung cancer candidate ASA404 after it once again failed to meet its …
News

Sanofi’s C diff vaccine fast tracked by FDA

November 10, 2010 Research and Development C diff, C diff vaccine, C difficile, Clostridium difficile, FDA, FDA fast-track, Sanofi, Sanofi Pasteur

A new vaccine aimed at preventing C difficile infections has been fast tracked by the FDA. The regulator’s decision signals …
News

Genzyme again snubs suitor Sanofi

November 10, 2010 Research and Development, Sales and Marketing Campath, Chris Viehbacher, Genzyme, Henri Termeer, Orphan Drugs, Plavix, Sanofi, Sanofi-Aventis, manufacturing compliance

Genzyme has once again snubbed Sanofi-Aventis as the French pharma firm continues its pursuit of the beleaguered biotech company. Henri …
News
Lilly headquarters

Lilly bolsters diagnostics presence with Avid acquisition

November 9, 2010 Research and Development Alzheimer's disease, Alzheimer’s disease, Avid Radiopharma, Eli Lilly, diabetes, emagacestat, florbetapir, lilly

Eli Lilly has acquired specialist diagnostics firm Avid Radiopharma in a deal that will bolster its diagnostics business. Philadelphia-based Avid …
News

Trial failure for Merck Serono’s Parkinson’s candidate

November 8, 2010 Research and Development Merck Serono, Newron Pharmaceuticals, Parkinson's disease, dopamine agonists, levodopa, safinamide

Merck Serono’s new alpha-aminoamide safinamide has failed to reach its primary endpoint in a study with Parkinson’s disease patients. Merck …
News

Roche’s melanoma candidate impresses in phase II trials

November 5, 2010 Research and Development BRAF protein, Cancer, Phase II, Plexxikon, RG7204, Roche

Roche’s mid-stage melanoma candidate has produced positive results in a difficult to treat cancer. RG7204 is an investigational, first-in-class molecule …
News

NicOx to halve HQ workforce

November 4, 2010 Research and Development, Sales and Marketing NicOx, job cuts, naproxcinod, pharma jobs

French pharmaceutical company NicOx is to halve the workforce at its Sophia Antipolis headquarters and is considering restructuring its Italian …
News

Biogen set to axe 650 jobs and focus on neurology

November 4, 2010 Research and Development, Sales and Marketing Biogen, Rituxan, job cuts, pharma jobs

Biogen Idec is set to cut hundreds of jobs and refocus its R&D in an effort to cut costs by …
News

Medivir appoints Charlotte Edenius

November 3, 2010 Research and Development Charlotte Edenius, Medivir, appointment, research and development

Swedish specialty pharmaceutical company Medivir has appointed Charlotte Edenius to the newly created position of VP of research and development …
Appointment

The utility of next generation sequencing in drug development

November 3, 2010 Research and Development Dr Cheng Eng Ang, Illumina, Source BioScience, drug development, genomics, human genome, next generation sequencing

Drug development studies are extremely expensive, costing many millions of pounds and taking up to 12 years to bring a …
Feature
Advanced melanoma

BMS skin cancer drug hits US regulatory delay

November 3, 2010 Research and Development BMS, Bristol-Myers Squibb, FDA, MDX010-020 trial, ipilimumab, skin cancer

US regulators have announced they need more time to assess Bristol-Myers Squibb’s skin cancer treatment ipilimumab. The FDA will not …
News

Almirall and Forest’s phase III COPD drug misses goal

November 3, 2010 Research and Development Aclidinium bromide, Almirall, COPY, Forest, Forest Laboratories, chronic obstructive pulmonary disease

Almirall and Forest’s COPD drug aclidinium bromide has disappointed in a phase III trial by producing fewer benefits than found …
News
The Gateway to Local Adoption Series

Latest content

Secarna appoints Jens Holstein and Richard Mark Engelhard to new Advisory Board

March 25, 2026

Roche adds 2,176 NVIDIA Blackwell GPUs to its hybrid-cloud AI factory

March 25, 2026

ReproNovo appoints Mark Altmeyer as Chairman of the Board

March 24, 2026

EndoCyclic New Drug application approved by US FDA for endometriosis treatment

March 24, 2026

Mestag Therapeutics appoints Lindsey Rolfe as Chief Medical Officer and Pascal Merchiers as Chief Development Officer

March 23, 2026